Maqui Berry and dry eyes

What 3 graded rows on maqui berry agree on for dry eyes, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Maqui Berry page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Maqui Berry page, with its PubMed record.

Supplement

Maqui Berry Choose another

3 rows · 107 people

They agree: all 3 rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade C, is a randomized trial of 74 people (2019) and found an improvement.

The rows run from 13 to 74 people, published from 2014 to 2023: 3 single studies.

3 improved

Grade CTear production and eye fatigue in screen workers with dry eyes · Improved
RCT · n 74 · 2019 · Japanese adults aged 30 to 60 with eye dryness and at least 4 hours of screen work a day
60 mg a day · 4 weeks
Tear production (Schirmer test) rose by 6.4 mm vs placebo (P = 0.005); eye fatigue after screen use (P = 0.047) and bothersome eye symptoms (P = 0.037) improved more than placebo. No adverse events.
Row on the Maqui Berry page · PubMed 31193920 (opens PubMed)
Grade DSigns, symptoms and tear inflammation in dry eye disease · Improved
RCT · n 20 · 2023 · Patients with dry eye disease at an eye hospital in Bengaluru, India
Dose not stated in the abstract · 2 months
The symptom score (OSDI) fell and Schirmer test rose vs placebo (p < 0.05); tear break-up time and corneal staining did not change. Tear IL-1β, IL-6, IL-17A, TNFα and MMP9 fell.
Row on the Maqui Berry page · PubMed 37026311 (opens PubMed)
Grade DTear volume and dry-eye quality of life · Improved
Open-label trial · n 13 · 2014 · Healthy volunteers with moderately dry eyes
30 mg or 60 mg a day · 60 days
Schirmer scores rose from 16.3 to 24.4 mm (30 mg) and from 18.7 to 27.6 mm (60 mg) after 30 days, and dry-eye quality-of-life scores improved in both groups.
Row on the Maqui Berry page · PubMed 25208615 (opens PubMed)